This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Medical Properties (MPW) Outpaced the Stock Market Today
by Zacks Equity Research
The latest trading day saw Medical Properties (MPW) settling at $3.23, representing a +1.89% change from its previous close.
Medical Properties (MPW) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
Medical Properties (MPW) closed at $3.10 in the latest trading session, marking a -1.9% move from the prior day.
Medical Properties (MPW) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
Medical Properties (MPW) reachead $3.28 at the closing of the latest trading day, reflecting a -0.91% change compared to its last close.
Medical Properties (MPW) Flat As Market Gains: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) concluded the recent trading session at $3.07, signifying no movement from its prior day's close.
Medical Properties (MPW) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
In the most recent trading session, Medical Properties (MPW) closed at $3.64, indicating a -0.55% shift from the previous trading day.
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Medical Properties (MPW) Q3 FFO Top Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of 8.57% and 11.53%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Is a Beat in Store for Medical Properties (MPW) in Q3 Earnings?
by Zacks Equity Research
Medical Properties' (MPW) Q3 earnings are likely to have benefited from the favorable operating trends of the healthcare industry and its disciplined capital allocation strategy.
Alpine Income (PINE) Lags Q3 FFO and Revenue Estimates
by Zacks Equity Research
Alpine Income (PINE) delivered FFO and revenue surprises of -5.13% and 0.41%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Medical Properties (MPW) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
Medical Properties (MPW) closed at $4.99 in the latest trading session, marking a +0.6% move from the prior day.
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Why the Market Dipped But (MPW) Gained Today
by Zacks Equity Research
Medical Properties (MPW) concluded the recent trading session at $5.30, signifying a +0.76% move from its prior day's close.
Want Better Returns? Don?t Ignore These 2 Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Medical Properties (MPW) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed at $5.28 in the latest trading session, marking a -1.12% move from the prior day.
Medical Properties (MPW) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed at $6.02 in the latest trading session, marking a -1.15% move from the prior day.
Medical Properties (MPW) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed the most recent trading day at $6.64, moving -1.34% from the previous trading session.
Medical Properties (MPW) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed at $7.29 in the latest trading session, marking a +0.97% move from the prior day.
Implied Volatility Surging for Medical Properties (MPW) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Medical Properties (MPW) stock based on the movements in the options market lately.
Is Invesco KBW Premium Yield Equity REIT ETF (KBWY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KBWY
Medical Properties (MPW) Beats on Q2 FFO, Narrows '23 View
by Zacks Equity Research
Medical Properties' (MPW) Q2 results reflect lower-than-anticipated revenues. Higher interest expenses during the quarter act as a dampener. The company narrows its 2023 outlook.
Medical Properties (MPW) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Medical Properties (MPW) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Medical Properties (MPW) Q2 FFO Top Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of 26.32% and 4.37%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Medical Properties (MPW) in Q2 Earnings?
by Zacks Equity Research
While Medical Properties' (MPW) Q2 earnings are likely to have benefited from the favorable healthcare industry trends and capital recycling efforts, high interest rates might have hurt it.
Sunstone Hotel Investors (SHO) Beats Q2 FFO and Revenue Estimates
by Zacks Equity Research
Sunstone Hotel (SHO) delivered FFO and revenue surprises of 6.45% and 0.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?